Development of Novel Epoxyketone-Based Proteasome Inhibitors as a Strategy To Overcome Cancer Resistance to Carfilzomib and Bortezomib Article

Lee, Min Jae, Bhattarai, Deepak, Yoo, Jisu et al. (2019). Development of Novel Epoxyketone-Based Proteasome Inhibitors as a Strategy To Overcome Cancer Resistance to Carfilzomib and Bortezomib . JOURNAL OF MEDICINAL CHEMISTRY, 62(9), 4444-4455. 10.1021/acs.jmedchem.8b01943

Open Access International Collaboration

cited authors

  • Lee, Min Jae; Bhattarai, Deepak; Yoo, Jisu; Miller, Zach; Park, Ji Eun; Lee, Sukyeong; Lee, Wooin; Driscoll, James J; Kim, Kyung Bo

sustainable development goals

authors

publication date

  • May 9, 2019

webpage

published in

keywords

  • APOPTOSIS
  • CELLS
  • Chemistry, Medicinal
  • EFFICACY
  • IMMUNOPROTEASOME
  • Life Sciences & Biomedicine
  • METABOLISM
  • MICROSOMAL EPOXIDE HYDROLASE
  • OPROZOMIB
  • Pharmacology & Pharmacy
  • REFRACTORY MULTIPLE-MYELOMA
  • SMALL-MOLECULE INHIBITOR
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • AMER CHEMICAL SOC

start page

  • 4444

end page

  • 4455

volume

  • 62

issue

  • 9